Advertisement

Three Boston-area companies are among 11 biotechnology firms nationwide to receive $1 million research awards from the Multiple Myeloma Research Foundation under the MMRF’s Biotech Investment Awards Program.

Constellation Pharmaceuticals Inc. of Cambridge, Epizyme Inc. of Cambridge and Karyopharm Therapeutics Inc. of Natick were among the 11 companies that received $1 million each for development of treatment of multiple myeloma.

SOURCE

Advertisement
Advertisement